A Study to Evaluate in Patients With Parkinsonian Type Disorders
Trial
Phase 2
Unknown
July 10, 2024
To Evaluate the Safety of DBS in Patients With Primary Parkinson's Disease
Trial
N/A
Unknown
July 9, 2024
Training With Exergame and Treadmill on Executive Function and Dual-task Performance
Trial
N/A
Completed
July 8, 2024
Safety and Efficacy of Adaptive Deep Brain Stimulation
Trial
N/A
Unknown
July 8, 2024
Mobilise-D: Extension Study
Trial
N/A
Unknown
July 7, 2024
A Safety and Pharmacokinetics Study of UCB7853 in Healthy Study Participants and Study Participants With Parkinson's Disease (PD)
Trial
Phase 1
Completed
July 7, 2024
IPG Replacement Study (PREFERENCE-H)
Trial
N/A
Completed
July 7, 2024
NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome
Trial
N/A
Unknown
July 7, 2024
Performance of the Paragit Sleeve to Measure and Monitor Motor Symptoms in Patients With Parkinson's Disease
Trial
N/A
Unknown
July 7, 2024
A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis
Trial
Phase 2
Completed
July 4, 2024
Research on the Brain Mechanism of taVNS in Regulating PD Motor Symptoms
Trial
N/A
Unknown
July 2, 2024
Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations
Trial
Phase 2
Completed
July 2, 2024
A Study of CST-103 Co-administered With CST-107 in Subjects With Parkinson's Disease Having Freezing of Gait (CLIN-012)
Trial
Phase 2
Withdrawn
July 2, 2024
Environmental and Reproductive Health Risk for Lewy Body Dementia
Trial
N/A
Unknown
July 2, 2024
BeatPark: Self-rehabilitation in Walking With Parkinson's Disease
Trial
N/A
Unknown
June 27, 2024
Non Motor Symptoms in Glucocerebrosidase-related Parkinson's Disease
Trial
N/A
Enrolling by invitation
June 27, 2024
Objective, Passive Assessment of LRRK2 Carriers
Trial
N/A
Completed
June 27, 2024
Balance Exercise and Vagus Nerve Stimulation on Weight-shifting Control and Ambulation in Parkinson Disease and Anxiety
Trial
N/A
Unknown
June 26, 2024
A Study to Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale
Trial
Phase 3
Terminated
June 25, 2024
Investigating Muscle Training's Respiratory Outcomes and Voice Enhancement in Parkinson's Disease
Trial
N/A
Not yet recruiting
June 24, 2024